Screener
Maze Therapeutics MAZE Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Maze Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Maze Therapeutics’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:48 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344903
FAQ
- What is Maze Therapeutics's restricted cash?
- Maze Therapeutics (MAZE) reported restricted cash of $1.09M in Q2 2026.
- How has Maze Therapeutics's restricted cash changed year-over-year?
- Maze Therapeutics's restricted cash decreased by 0.1% year-over-year, from $1.09M to $1.09M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Maze Therapeutics's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude